These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 24639190

  • 1. Toxicity of oxaliplatin plus fluorouracil/leucovorin adjuvant chemotherapy in elderly patients with stage III colon cancer: a population-based study.
    Hamza S, Bouvier AM, Rollot F, Lepage C, Faivre J, Bedenne L.
    Ann Surg Oncol; 2014 Aug; 21(8):2636-41. PubMed ID: 24639190
    [Abstract] [Full Text] [Related]

  • 2. Practical outcome of adjuvant FOLFOX4 chemotherapy in elderly patients with stage III colon cancer: single-center study in Korea.
    Kim JY, Kim YJ, Lee KW, Lee JS, Kim DW, Kang SB, Lee HS, Jang NY, Kim JS, Kim JH.
    Jpn J Clin Oncol; 2013 Feb; 43(2):132-8. PubMed ID: 23204187
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and safety of single agent or combination adjuvant chemotherapy in elderly patients with colon cancer: a Canadian cancer institute experience.
    Kim CA, Spratlin JL, Armstrong DE, Ghosh S, Mulder KE.
    Clin Colorectal Cancer; 2014 Sep; 13(3):199-206. PubMed ID: 25088184
    [Abstract] [Full Text] [Related]

  • 4. Severe enteropathy among patients with stage II/III colon cancer treated on a randomized trial of bolus 5-fluorouracil/leucovorin plus or minus oxaliplatin: a prospective analysis.
    Kuebler JP, Colangelo L, O'Connell MJ, Smith RE, Yothers G, Begovic M, Robinson B, Seay TE, Wolmark N.
    Cancer; 2007 Nov 01; 110(9):1945-50. PubMed ID: 17853393
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Adjuvant chemotherapy in stage III colon cancer: guideline implementation, patterns of use and outcomes in daily practice in The Netherlands.
    van Gils CW, Koopman M, Mol L, Redekop WK, Uyl-de Groot CA, Punt CJ.
    Acta Oncol; 2012 Jan 01; 51(1):57-64. PubMed ID: 22122695
    [Abstract] [Full Text] [Related]

  • 7. Safety and Efficacy of Oxaliplatin Doublet Adjuvant Chemotherapy in Elderly Patients With Stage III Colon Cancer.
    Brungs D, Aghmesheh M, de Souza P, Carolan M, Clingan P, Rose J, Ranson M.
    Clin Colorectal Cancer; 2018 Sep 01; 17(3):e549-e555. PubMed ID: 29861156
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stratified Survival Analysis After Adjuvant Chemotherapy of Colon Cancer Reveals a Benefit for Older Patients.
    Mayer B, Sander S, Paschke S, Henne-Bruns D, Link KH, Kornmann M, Study Group Oncology of Gastrointestinal Tumors (FOGT).
    Anticancer Res; 2015 Oct 01; 35(10):5587-93. PubMed ID: 26408730
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and toxicity of adjuvant chemotherapy in elderly patients with colon carcinoma: a 10-year experience of the Geisinger Medical Center.
    Fata F, Mirza A, Craig G, Nair S, Law A, Gallagher J, Ellison N, Bernath A.
    Cancer; 2002 Apr 01; 94(7):1931-8. PubMed ID: 11932894
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cetuximab plus FOLFOX-4 for fully resected stage III colon carcinoma: scientific background and the ongoing PETACC-8 trial.
    Taieb J, Puig PL, Bedenne L.
    Expert Rev Anticancer Ther; 2008 Feb 01; 8(2):183-9. PubMed ID: 18279058
    [Abstract] [Full Text] [Related]

  • 14. Biweekly oxaliplatin in combination with continuous infusional 5-fluorouracil and leucovorin (modified FOLFOX-4 regimen) as first-line chemotherapy for elderly patients with advanced gastric cancer.
    Liu ZF, Guo QS, Zhang XQ, Yang XG, Guan F, Fu Z, Wang MY.
    Am J Clin Oncol; 2008 Jun 01; 31(3):259-63. PubMed ID: 18525305
    [Abstract] [Full Text] [Related]

  • 15. Oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX-4) as salvage chemotherapy in patients with pretreated colorectal cancer.
    Shitara K, Munakata M, Muto O, Kasai M, Okada R, Mitobe S, Sakata Y.
    Gan To Kagaku Ryoho; 2007 Jul 01; 34(7):1079-84. PubMed ID: 17637544
    [Abstract] [Full Text] [Related]

  • 16. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089.
    Haller DG, Catalano PJ, Macdonald JS, O'Rourke MA, Frontiera MS, Jackson DV, Mayer RJ.
    J Clin Oncol; 2005 Dec 01; 23(34):8671-8. PubMed ID: 16314627
    [Abstract] [Full Text] [Related]

  • 17. Adjuvant chemotherapy and risk of gastrointestinal, hematologic, and cardiac toxicities in elderly patients with stage III colon cancer.
    Hu CY, Chan W, Delclos GP, Du XL.
    Am J Clin Oncol; 2012 Jun 01; 35(3):228-36. PubMed ID: 21383605
    [Abstract] [Full Text] [Related]

  • 18. Incidence of chemotherapy-induced amenorrhea in premenopausal women treated with adjuvant FOLFOX for colorectal cancer.
    Cercek A, Siegel CL, Capanu M, Reidy-Lagunes D, Saltz LB.
    Clin Colorectal Cancer; 2013 Sep 01; 12(3):163-7. PubMed ID: 23871161
    [Abstract] [Full Text] [Related]

  • 19. Impact of p53 expression and microsatellite instability on stage III colon cancer disease-free survival in patients treated by 5-fluorouracil and leucovorin with or without oxaliplatin.
    Zaanan A, Cuilliere-Dartigues P, Guilloux A, Parc Y, Louvet C, de Gramont A, Tiret E, Dumont S, Gayet B, Validire P, Fléjou JF, Duval A, Praz F.
    Ann Oncol; 2010 Apr 01; 21(4):772-780. PubMed ID: 19833818
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.